Prefilled Syringes Industry
The latest market report published by Credence Research, Inc. “Prefilled Syringes Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025,” the global prefilled syringes market was valued at US$ 8,631.3 Mn in 2016, and is expected to reach US$ 21,563.81 Mn by 2025 expanding at a CAGR of 9.98 % from 2017 to 2025.
The World Health Organization in its 2015 research survey has stated that in the last decade due to needle stick injury approximately 2 million healthcare professionals experienced percutaneous exposure to infectious diseases such as Hepatitis B and C virus, and HIV. Earlier, prefilled syringes were featured as add on safety devices, but technological advancement in the design aspect has introduced inbuilt safety mechanism. Unilife Corporation was the first manufacturer to market prefilled syringes with integrated safety features. Manufacturers are presently focusing on developing prefilled syringes with auto retractable needle technology and adopting integrated passive safety mechanism for prefilled syringes needle-stick safety.
Browse the full report Prefilled Syringes Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025 at https://www.credenceresearch.com/report/prefilled-syringes-market
Syringes were conventionally manufactured in bulk and consisted of several steps such as siliconization, washing and sterilization. Of late, the manufacturers are providing ready to fill pre-sterilized syringes, to save time and money bypassing the multiple steps involved during manufacturing operations.
Disposable prefilled syringes reduce the risk of infection due to needle-stick injury. Reusable prefilled syringes owing to its advantages such as easy dismantling and sterility, graduated cylinders to adjust IV bolus injection and autoclavable.
Glass prefilled syringes are used by healthcare professionals for the inherent feature of excellent chemical and thermal resistance. Due to features such as reduced surface reactivity, and decreased drug adsorption, plastic prefilled syringes are gaining importance in the market.
Diabetes dominated the applications segment of prefilled syringes on the account of rising disease prevalence and increasing demand for ready to administer dosages. Anaphylaxis will register good growth due to the use of prefilled syringes in emergency conditions arisen on account of anaphylactic shock reaction, and phenomenal growth in target patient population along with favorable government initiatives in developed markets.
The important players in prefilled syringes market are Nipro Medical Corporation, Bayer Healthcare, Vetter Pharma International GmbH, Biocon, Becton, Dickinson & Company, Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Owen Mumford, SCHOTT and Unilife Corporation.
Inquiry Before Buying: https://www.credenceresearch.com/inquiry-before-buying/58923
Based on type, the global prefilled syringes market is categorized into
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
Prefilled syringes have potential demand among healthcare professionals due offered advantages such as convenient drug delivery method and precise unit dose medication. Disposable prefilled syringes have excellent market on the account of increasing public awareness regarding needle safety and reduction in risk of contamination and infection as the syringes are disposed off immediately after single use. Reusable prefilled syringes are widely employed for drug delivery for chronic diseases as they are available as durable glass and plastic graduated cylinders to adjust the IV bolus and easy to dismantle, clean and autoclavable at 2730F. Important players in prefilled syringes market are Bayer Healthcare, Biocon, Becton, Dickinson & Company, Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Owen Mumford, SCHOTT, Unilife Corporation and Vetter Pharma International GmbH.
Key Market Movements:
- Rising prevalence of chronic ailments and increasing health awareness regarding needle stick injury
- Implementation and execution of Needlestick Safety and Prevention Act to protect healthcare professionals globally
- Increasing demand from homecare settings, and burgeoning requirement from pharmaceutical companies to formulate lyophilsed drugs in prefilled syringes
To know more insightful information, click here @ https://www.credenceresearch.com/sample-request/58923
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Designation: Global Sales Manager